{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T23:40:54Z","timestamp":1789083654640,"version":"build-2803163510"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","award":["T32 HL007534-36"],"award-info":[{"award-number":["T32 HL007534-36"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal.chestnet.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chest"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.chest.2020.02.047","type":"journal-article","created":{"date-parts":[[2020,3,14]],"date-time":"2020-03-14T11:26:59Z","timestamp":1584185219000},"page":"722-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Diffusing Capacity Is an Independent Predictor of Outcomes in Pulmonary Hypertension Associated With COPD"],"prefix":"10.1016","volume":"158","author":[{"given":"Aparna","family":"Balasubramanian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd M.","family":"Kolb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L.","family":"Damico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M.","family":"Hassoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith C.","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen C.","family":"Mathai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"293","key":"10.1016\/j.chest.2020.02.047_bib1","first-page":"1","article-title":"Mortality in the United States, 2016","author":"Kochanek","year":"2017","journal-title":"NCHS Data Brief"},{"issue":"11","key":"10.1016\/j.chest.2020.02.047_bib2","first-page":"289","article-title":"Employment and activity limitations among adults with chronic obstructive pulmonary disease: United States, 2013","volume":"64","author":"Wheaton","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.chest.2020.02.047_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1164\/ajrccm.164.2.2006129","article-title":"\u201cNatural history\u201d of pulmonary hypertension in a series of 131 patients with chronic obstructive lung disease","volume":"164","author":"Kessler","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2020.02.047_bib4","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1183\/09031936.00015608","article-title":"Pulmonary hypertension in COPD","volume":"32","author":"Chaouat","year":"2008","journal-title":"Euro Respir J"},{"issue":"6 Suppl","key":"10.1016\/j.chest.2020.02.047_bib5","doi-asserted-by":"crossref","first-page":"39S","DOI":"10.1378\/chest.10-0087","article-title":"Pulmonary hypertension in COPD: epidemiology, significance, and management: pulmonary vascular disease: the global perspective","volume":"137","author":"Minai","year":"2010","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chest.2020.02.047_bib6","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1378\/chest.107.5.1193","article-title":"Prognostic factors in COPD patients receiving long-term oxygen therapy","volume":"107","author":"Oswald-Mammosser","year":"1995","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2020.02.047_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1164\/rccm.200401-006OC","article-title":"Severe pulmonary hypertension and chronic obstructive pulmonary disease","volume":"172","author":"Chaouat","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"10.1016\/j.chest.2020.02.047_bib8","first-page":"993","article-title":"Long-term course of pulmonary arterial pressure in chronic obstructive pulmonary disease","volume":"130","author":"Weitzenblum","year":"1984","journal-title":"Am Rev Respir Dis"},{"issue":"1","key":"10.1016\/j.chest.2020.02.047_bib9","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1164\/ajrccm.159.1.9803117","article-title":"Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease","volume":"159","author":"Kessler","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"10.1016\/j.chest.2020.02.047_bib10","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1080\/15412555.2017.1336209","article-title":"Admission for COPD exacerbation is associated with the clinical diagnosis of pulmonary hypertension: results from a retrospective longitudinal study of a veteran population","volume":"14","author":"Medrek","year":"2017","journal-title":"COPD"},{"issue":"1","key":"10.1016\/j.chest.2020.02.047_bib11","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/15412555.2015.1043425","article-title":"Prevalence of pulmonary hypertension and its influence on survival in patients with advanced chronic obstructive pulmonary disease prior to lung transplantation","volume":"13","author":"Hayes","year":"2016","journal-title":"COPD"},{"issue":"3","key":"10.1016\/j.chest.2020.02.047_bib12","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.rmed.2013.11.006","article-title":"Clinical characteristics and prediction of pulmonary hypertension in severe emphysema","volume":"108","author":"Minai","year":"2014","journal-title":"Respir Med"},{"issue":"4","key":"10.1016\/j.chest.2020.02.047_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.healun.2011.11.020","article-title":"Prevalence, predictors, and survival in pulmonary hypertension related to end-stage chronic obstructive pulmonary disease","volume":"31","author":"Andersen","year":"2012","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.chest.2020.02.047_bib14","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S2213-2600(12)70044-9","article-title":"GOLD 2011 disease severity classification in COPDGene: a prospective cohort study","volume":"1","author":"Han","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.chest.2020.02.047_bib15","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/1465-9921-11-122","article-title":"Agusti A, Calverley PMA, Celli B, et al. Characterisation of COPD heterogeneity in the ECLIPSE cohort","volume":"11","year":"2010","journal-title":"Respir Res"},{"issue":"5","key":"10.1016\/j.chest.2020.02.047_bib16","doi-asserted-by":"crossref","first-page":"1900164","DOI":"10.1183\/13993003.00164-2019","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease: the GOLD science committee report 2019","volume":"53","author":"Singh","year":"2019","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2020.02.047_bib17","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1113\/jphysiol.1915.sp001710","article-title":"The diffusion of gases through the lungs of man","volume":"49","author":"Krogh","year":"1915","journal-title":"J\u00a0Physiol"},{"issue":"2","key":"10.1016\/j.chest.2020.02.047_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1152\/jappl.1957.11.2.290","article-title":"Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries","volume":"11","author":"Roughton","year":"1957","journal-title":"J\u00a0Appl Physiol"},{"issue":"6","key":"10.1016\/j.chest.2020.02.047_bib19","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.chest.2019.06.035","article-title":"Diffusing capacity of carbon monoxide in assessment of chronic obstructive pulmonary disease","volume":"156","author":"Balasubramanian","year":"2019","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2020.02.047_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.healun.2009.07.005","article-title":"Carbon monoxide diffusing capacity and mortality in pulmonary arterial hypertension","volume":"29","author":"Chandra","year":"2010","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"6","key":"10.1016\/j.chest.2020.02.047_bib21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jchf.2015.12.016","article-title":"Diffusion capacity and mortality in patients with pulmonary hypertension due to heart failure with preserved ejection fraction","volume":"4","author":"Hoeper","year":"2016","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10.1016\/j.chest.2020.02.047_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.healun.2018.09.011","article-title":"Survival in pulmonary hypertension due to chronic lung disease: influence of low diffusion capacity of the lungs for carbon monoxide","volume":"38","author":"Rose","year":"2019","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.chest.2020.02.047_bib23","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1378\/chest.06-1466","article-title":"Significance of pulmonary arterial pressure and diffusion capacity of the lung as prognosticator in patients with idiopathic pulmonary fibrosis","volume":"131","author":"Hamada","year":"2007","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.chest.2020.02.047_bib24","doi-asserted-by":"crossref","first-page":"1801913","DOI":"10.1183\/13993003.01913-2018","article-title":"Haemodynamic definitions and updated clinical classification of pulmonary hypertension","volume":"53","author":"Simonneau","year":"2019","journal-title":"Eur Respir J"},{"issue":"24","key":"10.1016\/j.chest.2020.02.047_bib25","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1001\/jama.2019.7233","article-title":"Discriminative Accuracy of FEV1:FVC thresholds for COPD-related hospitalization and mortality","volume":"321","author":"Bhatt","year":"2019","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.chest.2020.02.047_bib26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1164\/rccm.201701-0218PP","article-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive lung disease 2017 report. GOLD Executive Summary","volume":"195","author":"Vogelmeier","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"10.1016\/j.chest.2020.02.047_bib27","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1183\/09031936.05.00034805","article-title":"Standardisation of spirometry","volume":"26","author":"Miller","year":"2005","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.chest.2020.02.047_bib28","doi-asserted-by":"crossref","first-page":"1600016","DOI":"10.1183\/13993003.00016-2016","article-title":"2017 ERS\/ATS standards for single-breath carbon monoxide uptake in the lung","volume":"49","author":"Graham","year":"2017","journal-title":"Eur Respir J"},{"issue":"4","key":"10.1016\/j.chest.2020.02.047_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","article-title":"Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors","volume":"15","author":"Harrell","year":"1996","journal-title":"Stat Med"},{"issue":"12","key":"10.1016\/j.chest.2020.02.047_bib30","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0895-4356(96)00236-3","article-title":"A\u00a0simulation study of the number of events per variable in logistic regression analysis","volume":"49","author":"Peduzzi","year":"1996","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"3","key":"10.1016\/j.chest.2020.02.047_bib31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1081\/QEN-120001878","article-title":"Model-dependent variance inflation factor cutoff values","volume":"14","author":"Craney","year":"2002","journal-title":"Quality Engineering"},{"issue":"5","key":"10.1016\/j.chest.2020.02.047_bib32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s11135-006-9018-6","article-title":"A\u00a0caution regarding rules of thumb for variance inflation factors","volume":"41","author":"O\u2019Brien","year":"2007","journal-title":"Quality Quantity"},{"issue":"25","key":"10.1016\/j.chest.2020.02.047_bib33","doi-asserted-by":"crossref","first-page":"D109","DOI":"10.1016\/j.jacc.2013.10.036","article-title":"Pulmonary hypertension in chronic lung diseases","volume":"62","author":"Seeger","year":"2013","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.chest.2020.02.047_bib34","doi-asserted-by":"crossref","unstructured":"Gali\u00e9 N, Humbert M, Vachiery J-L, et al. 2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Respir J. 2015;46(4):903\u2013975.","DOI":"10.1183\/13993003.01032-2015"},{"issue":"8","key":"10.1016\/j.chest.2020.02.047_bib35","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1164\/rccm.201801-0095PP","article-title":"Pulmonary vascular involvement in chronic obstructive pulmonary disease. is there a pulmonary vascular phenotype?","volume":"198","author":"Kovacs","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.chest.2020.02.047_bib36","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/thx.36.10.752","article-title":"Prognostic value of pulmonary artery pressure in chronic obstructive pulmonary disease","volume":"36","author":"Weitzenblum","year":"1981","journal-title":"Thorax"},{"issue":"9","key":"10.1016\/j.chest.2020.02.047_bib37","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.healun.2017.02.016","article-title":"The Giessen Pulmonary Hypertension Registry: survival in pulmonary hypertension subgroups","volume":"36","author":"Gall","year":"2017","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"4","key":"10.1016\/j.chest.2020.02.047_bib38","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1183\/09031936.00078411","article-title":"ASPIRE registry: assessing the spectrum of pulmonary hypertension identified at a referral centre","volume":"39","author":"Hurdman","year":"2012","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.chest.2020.02.047_bib39","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1183\/09031936.00079512","article-title":"Pulmonary hypertension in COPD: results from the ASPIRE registry","volume":"41","author":"Hurdman","year":"2013","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2020.02.047_bib40","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1183\/13993003.02307-2014","article-title":"Severe pulmonary hypertension in lung disease: phenotypes and response to treatment","volume":"46","author":"Brewis","year":"2015","journal-title":"Eur Respir J"},{"issue":"10","key":"10.1016\/j.chest.2020.02.047_bib41","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa021322","article-title":"The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease","volume":"350","author":"Celli","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"9","key":"10.1016\/j.chest.2020.02.047_bib42","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1183\/09031936.93.03091042","article-title":"CO transfer capacity as a determining factor of survival for severe hypoxaemic COPD patients under long-term oxygen therapy","volume":"3","author":"Dubois","year":"1990","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2020.02.047_bib43","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1183\/09031936.93.04020141","article-title":"Lung CT density correlates with measurements of airflow limitation and the diffusing capacity","volume":"4","author":"Gould","year":"1991","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2020.02.047_bib44","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.ejrad.2015.01.010","article-title":"Relationships between diffusing capacity for carbon monoxide (Dlco), and quantitative computed tomography measurements and visual assessment for chronic obstructive pulmonary disease","volume":"84","author":"Nambu","year":"2015","journal-title":"Eur J Radiol"},{"issue":"12","key":"10.1016\/j.chest.2020.02.047_bib45","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1016\/j.healun.2013.09.007","article-title":"Pulmonary vascular abnormalities in chronic obstructive pulmonary disease undergoing lung transplant","volume":"32","author":"Peinado","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"3","key":"10.1016\/j.chest.2020.02.047_bib46","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.healun.2012.11.014","article-title":"Pulmonary arterial lesions in explanted lungs after transplantation correlate with severity of pulmonary hypertension in chronic obstructive pulmonary disease","volume":"32","author":"Carlsen","year":"2013","journal-title":"J\u00a0Heart Lung Transplant"},{"issue":"1","key":"10.1016\/j.chest.2020.02.047_bib47","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.chest.2019.02.333","article-title":"Pulmonary arterial histologic lesions in patients with COPD with severe pulmonary hypertension","volume":"156","author":"Bunel","year":"2019","journal-title":"Chest"},{"issue":"suppl 3","key":"10.1016\/j.chest.2020.02.047_bib48","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1513\/AnnalsATS.201312-443LD","article-title":"Pulmonary hypertension: NHLBI Workshop on the Primary Prevention of Chronic Lung Diseases","volume":"11","author":"Austin","year":"2014","journal-title":"Ann Am Thorac Soc"},{"issue":"3","key":"10.1016\/j.chest.2020.02.047_bib49","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.hlc.2013.08.003","article-title":"Lung function abnormalities are highly frequent in patients with heart failure and preserved ejection fraction","volume":"23","author":"Andrea","year":"2014","journal-title":"Heart Lung Circ"},{"issue":"11","key":"10.1016\/j.chest.2020.02.047_bib50","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1161\/01.CIR.91.11.2769","article-title":"Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure","volume":"91","author":"Puri","year":"1995","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.chest.2020.02.047_bib51","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1378\/chest.98.3.550","article-title":"Pulmonary diffusing capacity in left ventricular dysfunction","volume":"98","author":"Siegel","year":"1990","journal-title":"Chest"},{"issue":"21","key":"10.1016\/j.chest.2020.02.047_bib52","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1093\/eurheartj\/ehl302","article-title":"Gas diffusion and alveolar-capillary unit in chronic heart failure","volume":"27","author":"Agostoni","year":"2006","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.chest.2020.02.047_bib53","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1183\/09031936.00184412","article-title":"Severely reduced diffusion capacity in idiopathic pulmonary arterial hypertension: patient characteristics and treatment responses","volume":"42","author":"Trip","year":"2013","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2020.02.047_bib54","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.amjcard.2004.09.006","article-title":"New predictors of outcome in idiopathic pulmonary arterial hypertension","volume":"95","author":"Kawut","year":"2005","journal-title":"Am J Cardiol"},{"issue":"2","key":"10.1016\/j.chest.2020.02.047_bib55","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5603\/PiAP.2016.0006","article-title":"Low Dlco in idiopathic pulmonary arterial hypertension: clinical correlates and prognostic significance","volume":"84","author":"Szturmowicz","year":"2016","journal-title":"Adv Respir Med"},{"issue":"8","key":"10.1016\/j.chest.2020.02.047_bib56","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1016\/j.rmed.2009.03.009","article-title":"Pulmonary function testing in patients with pulmonary arterial hypertension","volume":"103","author":"Jing","year":"2009","journal-title":"Respir Med"},{"issue":"2","key":"10.1016\/j.chest.2020.02.047_bib57","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1378\/chest.129.2.378","article-title":"Diffusing capacity for nitric oxide and carbon monoxide in patients with diffuse parenchymal lung disease and pulmonary arterial hypertension","volume":"129","author":"Lee I van der","year":"2006","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.chest.2020.02.047_bib58","doi-asserted-by":"crossref","first-page":"343","DOI":"10.7326\/0003-4819-115-5-343","article-title":"Survival in patients with primary pulmonary hypertension: results from a national prospective registry","volume":"115","author":"D\u2019Alonzo","year":"1991","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.chest.2020.02.047_bib59","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1183\/09031936.00042107","article-title":"A\u00a0USA-based registry for pulmonary arterial hypertension: 1982-2006","volume":"30","author":"Thenappan","year":"2007","journal-title":"Eur Respir J"},{"issue":"2","key":"10.1016\/j.chest.2020.02.047_bib60","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.chest.2019.02.004","article-title":"Predicting survival in patients with pulmonary arterial hypertension: The REVEAL risk score calculator 2.0 and comparison with ESC\/ERS-based risk assessment strategies","volume":"156","author":"Benza","year":"2019","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2020.02.047_bib61","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018775056","article-title":"Pulmonary hypertension in chronic lung diseases: comparison to other pulmonary hypertension groups","volume":"8","author":"Chebib","year":"2018","journal-title":"Pulm Circ"},{"issue":"4","key":"10.1016\/j.chest.2020.02.047_bib62","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1183\/09031936.05.00021005","article-title":"Combined pulmonary fibrosis and\u00a0emphysema: a distinct underrecognised entity","volume":"26","author":"Cottin","year":"2005","journal-title":"Eur Respir J"},{"issue":"5","key":"10.1016\/j.chest.2020.02.047_bib63","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1378\/chest.127.5.1531","article-title":"Pulmonary hemodynamics in advanced COPD candidates for lung volume reduction surgery or lung transplantation","volume":"127","author":"Thabut","year":"2005","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.chest.2020.02.047_bib64","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/heart.89.2.225","article-title":"Chronic cor pulmonale","volume":"89","author":"Weitzenblum","year":"2003","journal-title":"Heart"},{"issue":"5","key":"10.1016\/j.chest.2020.02.047_bib65","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1183\/09031936.03.00115402","article-title":"Pulmonary hypertension in chronic obstructive pulmonary disease","volume":"21","author":"Barber\u00e0","year":"2003","journal-title":"Eur Respir J"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220304451?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369220304451?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T08:24:29Z","timestamp":1757924669000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369220304451"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S0012369220304451"],"URL":"https:\/\/doi.org\/10.1016\/j.chest.2020.02.047","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diffusing Capacity Is an Independent Predictor of Outcomes in Pulmonary Hypertension Associated With COPD","name":"articletitle","label":"Article Title"},{"value":"Chest","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chest.2020.02.047","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Inc under license from the American College of Chest Physicians.","name":"copyright","label":"Copyright"}]}}